Skip to content

Clinical trials

Terminated Phase 2/3 trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Status: Terminated Country / region: South Korea Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20081
20092
20101
20112
20123
20142
20152
20161
20171
20182
20193
20206
20212
20223
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated35

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seoul National University Bundang Hospital3
Alexion Pharmaceuticals, Inc.2
AstraZeneca2
Bristol-Myers Squibb2
Pfizer2
Theravance Biopharma2
AN2 Therapeutics, Inc1
AlloVir1
Boehringer Ingelheim1
CSL Behring1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases4
Colitis, Ulcerative3
Recurrence3
Alzheimer Disease2
COVID-192
Crohn Disease2
Stomach Neoplasms2
Stroke2
Acute Kidney Injury1
Adenoviridae Infections1

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.